Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Fujisawa and NeXstar team up to identify new immunological agents

April 12, 1999

Addition of Canadian sites to phase III WF-10 AIDS trial approved

April 12, 1999

LeIF adjuvant enhances therapeutic efficacy of leishmaniasis vaccine in humans

April 9, 1999

Stanford Rook establishes strategic research collaboration with Genesis

April 8, 1999

PowderJect presents positive data using PowderJect DNA vaccine

April 8, 1999

Aquila reveals new product in pipeline: CD1-TB

April 5, 1999

Merck & Co. presents new macrolide immunosuppressants

April 1, 1999

Aquila initiates phase IIb testing of Quilimmune-P

April 1, 1999

New patent expands protection for BioTransplant's AlloMune and XenoMune systems

March 23, 1999

Collaboration between Wyeth and Aviron for FluMist effective immediately

March 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...